Han KH - Search Results

1

Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.

Kim JK, Chang HY, Lee JM, Baatarkhuu O, Yoon YJ, Park JY, Kim DY, Han KH, Chon CY, Ahn SH. Kim JK, et al. Among authors: han kh. J Med Virol. 2009 Jun;81(6):1002-8. doi: 10.1002/jmv.21501. J Med Virol. 2009. PMID: 19382267

2

Factors predictive of response to interferon-alpha therapy in hepatitis C virus type 1b infection.

Yeh BI, Han KH, Lee HW, Sohn JH, Ryu WS, Yoon DJ, Yoon J, Kim HW, Kong ID, Chang SJ, Choi JW. Yeh BI, et al. Among authors: han kh. J Med Virol. 2002 Apr;66(4):481-7. doi: 10.1002/jmv.2169. J Med Virol. 2002. PMID: 11857525

3

Dose-response relationship in local radiotherapy for hepatocellular carcinoma.

Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. Park HC, et al. Among authors: han kh. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):150-5. doi: 10.1016/s0360-3016(02)02864-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182985

4

Immunogenetics of hepatitis B virus infection.

Han KH, Kim KH, Chang HY. Han KH, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S329-32. doi: 10.1046/j.1440-1746.17.s3.22.x. J Gastroenterol Hepatol. 2002. PMID: 12472958 Review. No abstract available.

5

[Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].

Lee CK, Suh JH, Cho YS, Han KH, Chung JB, Chon CY, Moon YM. Lee CK, et al. Among authors: han kh. Taehan Kan Hakhoe Chi. 2002 Jun;8(2):139-48. Taehan Kan Hakhoe Chi. 2002. PMID: 12499799 Korean.

6

[Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study].

Choi CH, Han KH, Kim DY, Cho JH, Cheong JY, Song KH, Chon CY, Moon YM. Choi CH, et al. Among authors: han kh. Taehan Kan Hakhoe Chi. 2002 Mar;8(1):52-60. Taehan Kan Hakhoe Chi. 2002. PMID: 12499817 Clinical Trial. Korean.

7

[Concurrent chemo-radiation therapy for advanced hepatocellular carcinoma with portal vein thrombosis].

Kim JS, Han KH, Lee DY, Seong JS, Youn YH, Cheong JY, Ahn SH, Chon CY, Moon YM. Kim JS, et al. Among authors: han kh. Taehan Kan Hakhoe Chi. 2002 Mar;8(1):71-9. Taehan Kan Hakhoe Chi. 2002. PMID: 12499819 Clinical Trial. Korean.

8

[Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection].

Lee CK, Suh JH, Cho YS, Han KH, Chung JB, Chon CY, Moon YM. Lee CK, et al. Among authors: han kh. Taehan Kan Hakhoe Chi. 2002 Dec;8(4):363-70. Taehan Kan Hakhoe Chi. 2002. PMID: 12506240 Korean.

9

[Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].

Joo HY, Han KH, Ryu WS. Joo HY, et al. Among authors: han kh. Taehan Kan Hakhoe Chi. 2002 Dec;8(4):371-80. Taehan Kan Hakhoe Chi. 2002. PMID: 12506241 Korean.

10

[Clinical efficacy of serum PIVKA-II in the diagnosis and follow up after treatment of hepatocellular carcinoma].

Yoon YJ, Han KH, Kim C, Chon CY, Moon YM, Han CH, Choi HJ, Kim YS, Han JY, Kim HS. Yoon YJ, et al. Among authors: han ch, han kh, han jy. Taehan Kan Hakhoe Chi. 2002 Dec;8(4):465-71. Taehan Kan Hakhoe Chi. 2002. PMID: 12506251 Korean.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,603 results

Search Page

Filters